regenerating blood vessels in the brain.
http://www.webpronews.com/stroke-treatment-reveals-targets-for-better-recovery-2012-12
From 2003
The ACCESS Study
Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
http://stroke.ahajournals.org/content/34/7/1699.short
-------------------------------------------------------------------------------------
The angiotensin-receptor blocker candesartan
for treatment of acute stroke (SCAST): a randomised, placebo-controlled,
double-blind trial
------------------------------------------------
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BDNF/TrkB system in rats
No comments:
Post a Comment